ED vs TXMD · P/E 18, rev $15.26B vs rev $1.8M
Consolidated Edison Inc (ED) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the ED and TXMD stock pages for the full models.
Not investment advice.